deoxyglucose has been researched along with Diabetic Neuropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alouffi, S; Khan, MWA | 1 |
| Akanuma, H; Ichiyanagi, K; Kawasaki, T; Ogata, N; Sakai, T; Watanabe, H; Yamanouchi, T | 1 |
| Feinendegen, LE; Gries, FA; Herzog, H; Kuwert, T; Langen, KJ; Mühlen, H; Ziegler, D | 1 |
| Anayat, AR; Eberl, S; Fulham, MJ; Fulton, RR; Hooper, PK | 1 |
| Akaoka, I; Funato, H; Inoue, T; Kawasaki, T; Koshibu, E; Miyashita, H; Ogata, N; Yamanouchi, T; Yoshimura, T | 1 |
| Hamada, Y; Horiuchi, S; Hotta, N; Kasuya, Y; Kato, K; Komori, T; Nagai, R; Nakamura, J; Naruse, K | 1 |
1 review(s) available for deoxyglucose and Diabetic Neuropathies
| Article | Year |
|---|---|
Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Insulin; Insulin Resistance; Isoenzymes; Lactoylglutathione Lyase; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
5 other study(ies) available for deoxyglucose and Diabetic Neuropathies
| Article | Year |
|---|---|
Postprandial plasma fructose level is associated with retinopathy in patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Fructose; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period; Prevalence | 2004 |
Cerebral glucose metabolism in type 1 diabetic patients.
Topics: Adult; Blood Glucose; Brain; Brain Stem; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diabetic Retinopathy; Evoked Potentials, Auditory; Evoked Potentials, Visual; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Motor Neurons; Neural Conduction; Neurons, Afferent; Reference Values; Time Factors | 1994 |
Evaluation of two population-based input functions for quantitative neurological FDG PET studies.
Topics: Adult; Autoradiography; Blood Specimen Collection; Brain; Central Nervous System Diseases; Deoxyglucose; Diabetic Neuropathies; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Regression Analysis; Tomography, Emission-Computed | 1997 |
Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.
Topics: Acetylglucosaminidase; Adult; Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Blood Proteins; Cholesterol; Cholesterol, HDL; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Regression Analysis; Sulfonylurea Compounds; Time Factors; Triglycerides | 1998 |
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Topics: Aldehyde Reductase; Blood Glucose; Blood Proteins; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Reference Values; Rhodanine; Thiazolidines | 2000 |